Head and neck cancers (ENT)
13 882 cancers of the lip, mouth and pharynx in France in 2023 1
What is it?
These cancers arise from the mucous membrane lining the mouth, pharynx (the throat, including the tonsils and base of the tongue) and larynx (the vocal cords). Almost all are squamous cell carcinomas, cancers of the surface cells 2.
How it develops
They may be preceded by visible lesions: a white patch (leukoplakia) or red patch (erythroplakia) in the mouth. Most of these patches do not become cancer: about 6,6 % of leukoplakias progress to cancer 3. The tumor may then reach the lymph nodes in the neck.
How long does it take to develop?
Cancers linked to human papillomavirus (HPV) appear several decades after infection 4. Those linked to tobacco and alcohol occur after years of exposure.
Risk factors
- Tobacco and alcohol, which greatly multiply the risk when combined
- Human papillomavirus (HPV), especially for cancers of the tonsils and base of the tongue
- Male sex and age
- Sun exposure for the lip
What helps protect you: Stopping smoking, reducing alcohol, HPV vaccination, a diet rich in fruit and vegetables 2.
Signs that should prompt a visit to your doctor
In the early stages
- Few or no signs
- Often painless
As it progresses
- A hoarse voice
- A wound or mouth ulcer that does not heal
- A sore throat, difficulty swallowing
- A lump in the neck
- A blocked nose on one side, ear pain
At an advanced stage
- Pain
- Difficulty breathing or eating
Across several stages
The “1 for 3” rule: see a doctor if just one of these signs lasts more than 3 weeks
These signs are often dismissed. Just one lasting more than 3 weeks? Talk to your doctor.
⁵See a doctor or dentist if any of these signs lasts more than a few weeks: a mouth sore that does not heal, a white or red patch, a persistent sore throat, difficulty swallowing, pain in one ear, an enlarged lymph node in the neck, a hoarse voice for more than 3 weeks 6.
Detected early or at a later stage
In the United States, only 1 in 4 cancers of the mouth or pharynx is found at the localized stage; 55 % at the regional stage (lymph nodes in the neck), 12 % distant 7.
5-year survival by stage
In France, 5-year net survival: lip-mouth-pharynx 41 % in men and 56 % in women; larynx 59 % 8.
Approximate correspondence with the clinical classification (TNM/FIGO); this varies depending on the tumour's characteristics.
Screening in France
No, there is no national program. Many early lesions are found during a mouth examination by a dentist or doctor 2.
Monitoring for people at risk
HPV vaccination for girls and boys aged 11 to 14, with catch-up vaccination up to age 26. Regular mouth examinations, especially for smokers and people who drink alcohol regularly 9.

Prevonco is currently available in France only.
An aid to the early detection of 16 cancers
No prescription needed, for people without symptoms. If you have an unexplained symptom, see your doctor first.
Pre-register for free →Frequently asked questions
Do I need a prescription?
No. With Prevonco, you do not need a prescription: after ordering online, a unique code gives you access to the test at one of our partner laboratories. In France, some laboratory tests can be carried out at your request, without a prescription.
No prescription, but still a doctor: they remain central to the process. Your result is sent to the doctor you selected from our panel, who will explain it during a 30-minute video consultation, included whatever the result.
Are you receiving care for cancer? Speak directly to your oncologist: they can prescribe this test without going through Prevonco.
For any questions about your situation, or if you have symptoms, your doctor remains your first point of contact.
What if my level is high?
A high level tends to be a strong signal. It is not a conclusion: its cause needs to be investigated with a doctor.¹⁰
Your result is sent to the doctor you selected from our panel. They will explain it during the 30-minute video consultation included in the price. Further investigations prescribed by a doctor can help identify the cause.¹⁰
What if the level is intermediate? It may not be related to cancer (smoking, an inflammatory condition, etc.). Other blood tests may be suggested; if they are normal, a repeat check is planned at 12 months. You will never be left to face your result alone.¹⁰
What if my level is low?
That is reassuring, but no test is perfect: a low level does not rule everything out.¹⁰
If you have no symptoms, no specific follow-up is recommended after a low result. The risk of a false negative varies by cancer type.¹⁰
Your doctor, who is trained in functional medicine and specialises in prevention, will help you explore any concerns or symptoms during the 30-minute video consultation.¹⁰
Keep up with your usual screening: respond to invitations for organised screening programmes, and see your doctor if a symptom appears.¹⁰
How long will it take to get my results?
The laboratory analysis takes 30 days. Your full results are presented by a doctor trained in functional medicine during a 30-minute consultation included in your package.
You choose the date and time slot that suit you for this appointment.
Prevonco is currently available in France only.
An aid to the early detection of 16 cancers
No prescription needed, for people without symptoms. If you have an unexplained symptom, see your doctor first.
Pre-register for free →General information for educational purposes: it does not replace your doctor's advice. An aid to early detection: it does not replace organised screening, imaging tests or your doctor's advice.
Sources
- 1.INCa, Panorama des cancers en France, 2026
- 2.American Cancer Society, oral cavity and oropharyngeal cancer – risk factors
- 3.Pimenta-Barros et al., Oral Diseases, 2024 : transformation des leucoplasies
- 4.ISPOR, 2024 : délai entre infection HPV et cancer de l’oropharynx
- 5.Gustave Roussy (2020); INCa (tool for doctors, 2018); Assurance Maladie; Fondation ARC
- 6.Cancer Research UK, laryngeal cancer symptoms
- 7.NCI SEER, Cancer Stat Facts – Oral Cavity and Pharynx Cancer (2016-2022)
- 8.Santé publique France, survie 1989-2018 – lèvre, bouche, pharynx
- 9.Vidal, Gardasil 9 remboursé jusqu’à 26 ans, 2025
- 10.biodena.care